- Boustead Securities
Flora Growth to Acquire Koch & Gsell and Enter Europe with Leading Manufacturer of Hemp Products
Heimat, Koch & Gsell’s leading brand that includes pure hemp and blended hemp and tobacco cigarettes, to amplify revenue growth for Flora’s CPG portfolio with trailing twelve-month revenues of US$7.6M
Flora to acquire 100% of Koch & Gsell for consideration of CHF 20 million (Swiss Francs, ~US$22.2M), to be satisfied by means of Flora common shares at a price of US$5.00 per share
Acquisition to accelerate distribution of Flora Growth’s portfolio into Europe and Asia
Heimat’s manufacturing technology to support Flora’s market share growth
Toronto, Ontario & Irvine, CA – June 16, 2021 -- Boustead Securities IPO client Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce it has signed a Letter of Intent (“LOI”) to acquire 100% of the outstanding equity interests of Switzerland based Koch & Gsell and its wholly-owned hemp brand, Heimat.
Under the Heimat brand, Koch & Gsell manufactures and distributes a range of hemp products that contain less then 1% THC, including pure hemp and blended hemp and tobacco cigarettes, as well as bulk flower and teas in over 2,500 stores across Switzerland. Heimat has become one of the leading brands in the Swiss market for industrially manufactured hemp cigarettes. Koch & Gsell distributes its Heimat pure hemp cigarettes and a variety of Swiss grown hemp flowers in Luxembourg and Belgium, expanding fast throughout Europe and standing at the doorstep to Asian countries.
The Heimat brand, if acquired, will represent a substantive addition to the Flora brand portfolio as a high growth brand, with trailing twelve-month revenues of US$7.6M. Pursuant to the terms of the LOI and subject to the definitive acquisition agreement and approvals, upon the closing of the transaction, Flora will also invest CHF 2 million (Swiss Francs), or approximately US$2.2M, to rapidly grow the Heimat brand into new markets and to strengthen Heimat’s position in the Swiss market. Further, by leveraging Koch & Gsell’s existing distribution network, Flora plans to introduce its brand portfolio, including Mind Naturals, Mambe, and Almost Virgin, to the Swiss and European market.
Following consummation of the transaction, Koch & Gsell will continue to be led by Founder and CEO, Roger Koch, who has been responsible for growing the Heimat brand across Switzerland and into new international markets in Europe and Asia.
As part of the transaction, Flora anticipates acquiring all of Koch & Gsell’s hemp, blended hemp and tobacco cigarette manufacturing technology. The proprietary cigarette manufacturing technology can produce over 40,000 packs of 20 cigarettes per day. The technology is patented in over 80 jurisdictions throughout the world, where Flora anticipates bringing this technology into new markets to produce hemp, cannabis, or blended cigarette products, utilizing Flora’s high-quality, low-cost cannabis input.
“The proposed acquisition of Koch & Gsell is a testament to our growth strategy. We are looking for partners that complement our distribution, enhance our supply chain and generate meaningful revenues in core markets that complement our existing portfolio of products and our premium cannabis inputs,” said Luis Merchan, CEO of Flora. “Not only are we attracted to Koch & Gsell’s exceptional penetration in brick-and-mortar grocery stores, but also their proprietary technology to create authentic pure hemp and hemp & tobacco/herbal cigarettes at an industrial scale, which we believe will be a major product category for the global cannabis space in the years to come.”
About the Proposed Transaction
Flora has signed an LOI to acquire 100% of the outstanding equity interests of Koch & Gsell for consideration of CHF 20 million (Swiss Francs), or approximately US$22.2M, to be satisfied by the issuance of Flora common shares at a deemed price of US$5.00 per share (the “Flora Share Price”). The closing of the transaction will be subject to customary closing conditions, including due diligence to the satisfaction of both parties and the entering into of definitive agreements.
About Koch & Gsel
Koch & Gsell (K&G) is a Swiss brand and manufacturing company founded in 2015, that launched a new, innovative tobacco-and-hemp cigarette, which caused a stir across the world. In summer 2019, K&G further launched an industrially manufactured pre-roll cigarette containing pure hemp and has taken steps to protect the method they use to manufacture their hemp products. K&G believes in the gentle yet compelling power of Cannabidiol (CBD) as a relief for many of today’s lifestyle diseases. Much is yet to be discovered, but the tremendous potential of CBD as a powerful alternative to pharmaceuticals is obvious and needs to be made available to customers across the world.
About Flora Growth Corp.
Flora Growth is a cannabis company that will leverage natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.floragrowth.ca or follow @floragrowthcorp on social for more information
About Hoshi International Inc.
Hoshi is a European focused, fully integrated medical cannabis company led by a team of renowned cannabis entrepreneurs. Hoshi is focused on developing and operationalizing assets across the global cannabis industry with an emphasis on cultivating, manufacturing, and distributing cannabis derived products. Hoshi is uniquely positioned to be a leading provider of cannabis and derivative products for the emerging European market.
About Boustead Securities, LLC
Boustead Securities, LLC is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead’s core value proposition is the ability to create opportunity through innovative solutions and tenacious execution. With experienced professionals in the United States, Boustead’s team moves quickly and provides a broad spectrum of sophisticated financial advice and services. Boustead is a majority-owned subsidiary of Boustead & Company Limited, a diversified non-bank financial institution. For more information visit please visit: www.boustead1828.com
For Underwriter Inquiries Please Contact:
Boustead Securities, LLC
Daniel J. McClory, Head of Equity Capital Markets
Tel: +1 949 502 4408
Form CRS/Reg BI Disclaimer:
Boustead Securities, LLC, Sutter Securities Inc., and Sutter Securities Clearing, LLC (SSC) are registered with the Securities and Exchange Commission (SEC) as broker-dealers and are members of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC). Brokerage and investment advisory services and fees differ and it is important for you to understand these differences. Free and simple tools are available to research firms and financial professionals at Investor.gov/CRS, which also provides educational materials about broker-dealers, investment advisers, and investing. When we provide you with a recommendation, we have to act in your best interest and not put our interest ahead of yours. At the same time, the way we make money creates a conflict with your interests. Please strive to understand and ask us about these conflicts because they can affect the recommendations we provide you. There are many risks involved with investing. For Boustead Securities customers and clients, please see our Regulation Best Interest Relationship Guide on the Form CRS Reg BI page on our website at https://www.boustead1828.com/form-crs-reg-bi. For Sutter Securities’ and Sutter Securities Clearing’s customers and clients, please see the Form CRS on the website at https://suttersecurities.com/wp-content/uploads/2020/12/Sutter-Form-CRS-combined-121020.pdf. For FlashFunders’ visitors, you may review the Form CRS of Boustead Securities, Sutter Securities and Sutter Securities Clearing under the Form CRS section. Please also carefully review and verify the accuracy of the information you provide us on account applications, subscription documents and others.
Cautionary Statement Concerning Forward-Looking Statements
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.